TERN - Terns falls as phase 2 data on oral GLP-1 obesity asset disappoints
2025-10-21 17:47:06 ET
More on Terns Pharmaceuticals
- Terns Pharmaceuticals: Valued As If It Can't Win
- Terns Pharmaceuticals, Inc. (TERN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Terns Pharmaceuticals, Inc. - TERN-701 Investor Educational Webinar Transcript
- Seeking Alpha’s Quant Rating on Terns Pharmaceuticals
- Historical earnings data for Terns Pharmaceuticals